CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
Liang Yan,1,* Xiuyun Tian,1,* Chunxiang Ye,1,2 Xiaoya Guan,1 Bin Dong,3 Min Zhao,4 Jianhui Wu,1 Chunyi Hao1 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepato-Pancreato-Biliary Surgery, Peking University Cancer Hospital & Instit...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-12-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/cd26-as-a-promising-biomarker-for-predicting-prognosis-in-patients-wit-peer-reviewed-article-OTT |